Singapore Innovation & Enterprise Showcase 2025

The 3rd Singapore Innovation & Enterprise showcase will be back on 15 January 2025 at San Francisco Marriott Marquis, during the week of the J.P. Morgan Annual Healthcare Conference. Join us to meet Singapore’s most innovative startups for an exciting exchange of ideas and connect with innovators and investors.

Discover Singapore's most innovative startups

• Innovative companies in targeted therapies and drug discoveries: Ananda Immunotherapies, AUM Biosciences, Avecris, Axcynsis Therapeutics, BioSyngen, DotBio, Immunoscape, KYAN Technologies, Nuevocor, PairX Bio, Paratus Sciences, Tikva Allocell and VerImmune 
• Champions in data driven care delivery: Aevice Health, Biorithm, CoNEX Healthcare, MeshBio, Oncoshot, Respiree
• Diagnostic champions empowering precision cancer care: Auristone, BioCheetah, Lucence, Qritive
• Surgical robotic visionaries: NousQ, Vivo Surgical

Meet our panelists: Learn about the Singapore biomedical ecosystem and regional opportunities

• Amy Schulman, Managing Partner, Polaris Partners: Polaris Partners has been actively investing in Singapore for over 6 years. Amy sits on the board of various Singapore entities, including Singapore’s Human Health and Potential International Advisory Council, National Medical Research Council, Singapore Therapeutics Development Review Expert Review Panel and ClavystBio. She frequently works with local partners, to foster effective collaboration between the US and Singapore.

• Ansbert Gadicke, Managing Partner, MPM Bioimpact: MPM Bioimpact, a US-based biotechnology investment firm, has recently expanded into Asia, partnering with Singapore’s Agency for Science, Technology and Research (A*STAR) to create biotech spinoffs. Learn about their outlook on growth in Asia Pacific and Singapore’s growing prominence as a biomedical hub.

• Alessandro Falcone, Head, JLABS Singapore, Johnson & Johnson: JLABS Singapore celebrated its first anniversary in October 2024, with a growing portfolio of high-potential companies, and network of local and regional partners. Find out more about interesting innovations from Singapore and collaboration opportunities with MNCs.

• Hugo Saavedra, Co-founder & CEO, KYAN Technologies: KYAN Technologies provides functional precision medicine solutions for cancer patients by combining Small Data AI and biological experiments. Learn how the company has leveraged the Singapore ecosystem to grow and expand into the US.

• Irene Cheong, Assistant CEO, A*STAR (moderator): The Agency for Science, Technology and Research (A*STAR) is Singapore’s lead public sector R&D agency that advances scientific discovery and technological innovation.

Jointly organised with: